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Abstract
BACKGROUND: In 2018, there were approximately 234,030 new lung cancer diagnoses and
154,500 lung cancer deaths in the United States. Kentucky leads the nation in new lung cancer
cases each year. The USPSTF estimates that 10% to 12% of lung cancers detected by routine
screening would not have been detected until the cancer advanced; therefore, the USPSTF
recommends yearly lung cancer screenings using low dose CT (LDCT) scans of the chest for
patients 55 to 80 years old who have a 30 pack-year smoking history and are currently smoking
or have quit within the last 15 years.
PURPOSE: The purpose of this project was to increase smoking history documentation,
including pack-years, and LDCT orders for patients 55 to 80 years old who meet screening
criteria in a primary care setting.
METHODS: The FOCUS-PDSA model for improvement was used to guide this quality
improvement project. Four PDSA cycles using variations of prompts for screening (eg. lung
cancer screening flyers and smoking history stickers on patient intake document) were conducted
to identify the best strategies for increasing smoking history documentation, including packyears and increasing LDCT orders. Retrospective and prospective chart reviews were completed
for smoking history documentation and LDCT orders before and after the interventions.
RESULTS: There were no significant differences in each PDSA cycle for smoking history
documentation (p=0.64) or LDCT orders (p=0.44). PDSA cycles one, two, and four showed a
non-significant increase in documentation and orders. Current smokers were more likely to
receive LDCT orders than former smokers who met eligibility criteria (p=0.05).

Running head: INCREASING LUNG CANCER SCREENING RATES
CONCLUSIONS: Findings suggest that reminders like, educational lung cancer screening
flyers, and smoking history stickers could increase documentation and LDCT scan orders. More
research is needed comparing lung cancer screening orders between current and former smokers.
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Increasing Smoking History Documentation and Lung Cancer Screening Orders in a
Primary Care Clinic
Problem Description
Lung cancer is the leading cause of cancer-related mortality for adults in the United
States (CDC, 2018). In 2018, there were approximately 234,030 new cases diagnosed and
154,500 deaths from lung cancer in the U.S. (National Cancer Institute, 2019). Current or past
use of tobacco through cigarettes, pipes, and cigars is the leading risk factor for lung cancer
(National Cancer Institute, 2019). Cigarette smoking is linked to 80% to 90% of lung cancer
deaths in the United States and smoking makes a person 15 to 30 times more likely to be
diagnosed with or die from lung cancer (CDC, 2018).
Kentucky leads the nation in new lung cancer cases each year. The incidence of new lung
cancer cases in Kentucky is 96.8 per 100,000 compared to 63.0 per 100,000 nationally. In
addition, the rate of lung cancer deaths per 100,000 people in the state is 64.3 compared to 40.6
nationally (U.S. Cancer Statistics Working Group, 2018). Finally, in Kentucky, the 5-year
survival rate is 16.8 percent compared to 20.0 percent nationally (American Lung Association,
2018).
The United States Preventative Services Task Force (USPSTF) recommends yearly lung
cancer screenings using low-dose computerized tomography (LDCT) scans of the chest for
patients who are 55 to 80 years old, have a 30 pack-year smoking history, and are currently
smoking
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or have quit within the last 15 years. This should be discontinued when a patient has not smoked
for longer than 15 years or develops a problem or illness that greatly reduces their life
expectancy (Humphrey et al., 2013). The National Lung Screening Trial Team (2011) found a
20% decrease in lung cancer mortality when screening was completed by a LDCT scan, and the
USPSTF estimates that 10% to 12% of lung cancers detected by routine screening would not
have been detected until the cancer advanced. Therefore, the USPSTF recommends routine
screenings to catch lung cancer earlier, when treatment is more effective (American Lung
Association, 2018; Humphrey et al., 2013).
Despite the USPSTF recommendation for yearly screenings, screening rates remain as
low as 2% across the country (Davenport, 2018). Because of a lack of uniform documentation of
pack-years among current and former smokers, the national screening rate is an estimate.
Documentation challenges also make it difficult to determine the screening rate for Kentucky.
However, 18.1% of lung cancer cases are caught early in Kentucky, when the rate of survival is
48.8%, and 52.5% of cases are caught during the late stages of cancer, when the survival rate is
only 3.2% (U.S. Cancer Statistics Working Group, 2018). Increasing lung cancer screening rates
in Kentucky should increase the amount of cases caught early, therefore reducing morbidity and
mortality.
Available Knowledge
There are environmental, occupational, and genetic causes for both small cell lung cancer
(SCLC) and non-small cell lung cancer (NSCLC). The risk factors for both types of lung cancers
are similar. Increasing age is a risk factor but a history of or current use of tobacco through
cigarettes, pipes, and cigars is the leading risk factor for both types of lung cancer (National
Cancer Institute, 2019). Radon is the number one cause of lung cancer among people who do not
7

INCREASING LUNG CANCER SCREENING RATES
smoke tobacco and is overall the second leading cause of lung cancer (Environmental Protection
Agency, 2018).
Other causes of lung cancer include exposure to asbestos, arsenic, chromium, beryllium,
nickel, diesel exhaust, and some forms of silica (CDC, 2018; National Cancer Institute, 2019).
Radiation treatments to the chest, radiation exposure from medical testing, and radiation from
atomic bombs also increase a person’s risk (National Cancer Institute, 2019). A family history of
lung cancer also increases the risk of developing the disease. The dietary supplement, betacarotene, is also found to increase incidences of lung cancer in smokers (CDC, 2018; National
Cancer Institute, 2019)
Rationale
Research shows that the three main reasons for a low lung cancer screening rate are lack
of documentation of adequate smoking histories, including pack-years asked, and lack of patient
and provider knowledge about screening (Kanodra et al., 2016; Li, Chung, Wei, and Luft, 2018;
Rajupet et al., 2017; Raz et al., 2018). Also, some providers disagree with screening all together
due to the potentially invasive procedures that might follow a positive LDCT scan and the
potential for false positives (Li, Chung, Wei, & Luft, 2018; Rajupet et al., 2017).
Identifying patients with a 30 pack-year smoking history is the first step to screening them for
lung cancer and implementing smoking cessation interventions (Polubriaginof, Salmasian,
Albert, & Vawdrey, 2018; Modin et al., 2016).
Davenport (2018) suggests that one of the most common reasons for low screening rates
is a lack of documentation of accurate smoking histories with the number of pack-years. Many
patients are aware of other screenings, such as those for breast, colon and cervical cancer, but
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have never been educated about lung cancer screenings (Cardarelli et al., 2017). Many providers
ask if the patient is a current smoker or former smoker, but do not ask for any specifics about
when the patient started, how many packs per day they smoked and when or if they quit smoking
(Albert, & Vawdrey, 2018; Modin et al., 2016). Possible reasons for this include a lack of time
or, forgetfulness due to so many other necessary screenings (Raz et al., 2018; Simmons et al.,
2017). Knowing a patient’s smoking history will help the provider make decisions about
screening and, most importantly for lung cancer prevention, implement smoking cessation
interventions (Li et al., 2018).
Smoking history documentation increases with prompting interventions such as notecards
or notepads with smoking history questions printed on them. Electronic reminders might also
prompt discussion and documentation of a patient’s smoking history (Polubriaginof, Salmasian,
Albert, & Vawdrey, 2018; Modin et al., 2016). Li, Chung, Wei, and Luft (2018) suggest that
lung cancer screening compliance can be increased by recording an accurate smoking history in a
standardized location within the patient’s health record. This would also help with recording
accurate local and national screening rates.
Many patients who should be screened for lung cancer, have never heard of the
recommendation, but would be receptive to it if they did (Kanodra et al., 2016). Lack of patient
awareness of the specifics of the screening recommendation is a barrier to lung cancer screening
because patients are less likely to think it is important, and less likely to ask their primary care
provider about it (Kanodra et al., 2016; Raz et al. 2019; Wang et al., 2019). Cardarelli et al.
(2017) explored patient knowledge of lung cancer screening in Appalachian Kentucky. The
overwhelming majority of their participants did not know anything about lung cancer screening
with an LDCT scan of the chest. Knowledge can be increased about lung cancer screenings by
9
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displaying posters or pamphlets in the clinic waiting room, mailing postcards, or other
advertisements on the Internet and in retail stores (Cardarelli et al., 2017; Fintelmann et al.,
2015).
Primary care providers may also not be aware of current lung cancer screening
guidelines, or they may not believe in the efficacy of the screening (Raz et al., 2018; Simmons et
al., 2017; Wang et al., 2019). Providers might be ordering chest x-rays instead of LDCT scans to
screen for lung cancer even though this is not recommended and has been shown to be less
effective than LDCT scans (Humphrey et al., 2013; Lewis et al., 2016). While most providers
view lung cancer screening as important, some do not see the effectiveness of screening due to
costs, unnecessary radiation exposure, and the risk of false positives (Raz et al., 2018; Simmons
et al., 2017).
While there are evidenced-based interventions available, they are not being used enough
as shown by nationally low screening rates. While research suggests increasing smoking history
documentation is more likely to increase screening rates, more research is needed to indicate if
more patient education will increase screening rates (Modin et al., 2016). Also, more
investigation is needed to find out which interventions work best to increase documentation and
patient education to increase screening rates.
Specific Aims
The purpose of this quality improvement project was to increase smoking history
documentation and lung cancer screening orders for patients aged 55 to 80 years old, who qualify
for routine LDCT scans according to the USPSTF recommendation.
Objective 1: Evaluate the effect of various Plan-Do-Study-Act (PDSA) cycles to increase
documentation of an adequate smoking history.
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Objective 2: Evaluate the effect of various PDSA cycles to increase orders for LDCT among
patients who qualify.
Methods
Context
This project took place at an urban family-medicine clinic in an academic medical center
located in central Kentucky. The clinic provides primary care services for patients of all ages in
the Commonwealth of Kentucky. The clinic has a family medicine residency-training program
for physicians. This program requires first, second, and third year residents, and Doctor of
Nursing Practice (DNP) students, if available, to complete a quality improvement project within
the clinic every year. A quality improvement team was organized to improve the current rate of
lung cancer screening orders within the clinic. The group met once a month between November
2018 and June 2019 to create a new process for increasing lung cancer screenings using the
FOCUS-PDSA model for improvement. Where FOCUS stands for 1.) Find a Process to Improve,
2.) Organize a team, 3.) Clarify current knowledge, 4.) Understand the problem, 5.) Select a
process to improve. Four PDSA cycles were completed between April 2019 and June 2019.
Intervention
The quality improvement team was guided by facilitators from the institution’s Office for
Value and Innovation in Healthcare Delivery (OVIHD). The teams used the FOCUS-PDSA
model for improvement for the project process and completion. The FOCUS-PDSA model
consists of two stages with individual steps to guide quality improvement initiatives. The
FOCUS stage is the first stage, where an action plan is developed. The PDSA stage is the second
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stage and consists of small cycles of change to implement the action plan (Center for Health
Services Research, 2019).
Stage One: Develop an Action Plan
Find a Process to Improve
The quality improvement team decided to evaluate the lung cancer screening rate at the
clinic. Personal experience with cancer survivors involving screening before and after cancer
diagnoses inspired this project. Nationally, only about 2% of current smokers who qualify for
screening, are being screened (Davenport, 2018). At the time of this project, 18% of current
smokers within the clinic aged 55 to 80 years had received lung cancer screenings with LDCT
within the last year. Both rates are estimates because the team was unable to determine packyears, nationally, and within the clinic. Because of the lack of documentation of pack-years, the
team had to estimate UK Family Medicine’s screening rate using the number of current smokers
aged 55-80 years who received screening, by the total number of current smokers in the clinic
aged 55-80 years. Baseline data were impossible to find for former smokers due to lack of
documentation.
Organize a Team
The quality improvement team consisted of six first through third year family medicine
residents, one Doctor of Nursing Practice (DNP) student, and two family medicine attending
physicians. The team was assigned through a residency education program within the clinic.
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Clarify Current Knowledge
Because only 18% of current smokers aged 55-80 years are being screened with LDCT,
the quality improvement team first needed to clarify the current process for lung cancer
screening within the clinic. The team discussed the current process with clinical services
technicians (CST) and providers, including physicians and nurse practitioners, and created a flow
chart (see Figure 3). During the rooming process, the CST obtains vital signs, completes a
medication reconciliation, and if needed, completes an annual review which asks safety and
lifestyle questions. During the annual review, the CST only asks the patient about current and
former smoking status but does not include pack-years. After the CST is finished, the provider
enters the room and has twenty minutes to review the patient’s chief complaint and physical
exam. If there is time, the provider reviews necessary health screenings with the patient. After
the appointment, the provider orders medications, testing, and screening as necessary based on
the appointment.
Understand the Problem
To understand the problem, the quality improvement team created a fishbone diagram
(see Figure 4) and Five Whys flowchart (see Figure 5). The fishbone diagram explored elements
within the organization, tasks, technology, people, and environment that contribute to low lung
cancer screening rates in the clinic. The five why’s chart narrowed down reasons for low lung
cancer screening rates. Both tools showed that providers and CSTs forget to ask full smoking
histories including pack-years.
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Select a Process to Improve
The quality improvement team decided to focus on improving the process for obtaining
full smoking histories to increase the lung cancer screening rates within the clinic. The team
created a specific, measurable, attainable, relevant and time bound goal. The goal, by the end of
June 2019, was to increase smoking history documentation and lung cancer screening orders by
three percent for patients aged 55 to 80 years old who qualify for routine LDCT scans according
to the USPSTF recommendation over a three-month period.
Stage Two: Implementation of Action Plan
PDSA cycles are rapid cycles of change. First, an intervention is planned (Plan), then the
intervention is carried out (Do), and the outcomes are evaluated (Study). The final step is to
adopt or abandon the intervention (Act; Center for Health Services Research, 2019). The results
of one cycle help to guide the process and planning for the subsequent cycles until a process is
adopted. The PDSA cycles and their outcomes are described later in the results section.
Lewin’s Change Theory
Prior to implementing the PDSA change model, the team considered Lewin’s change
theory for planning and implementing change. Changing behavior is difficult, and many theorists
have analyzed steps towards making lasting change. Kurt Lewin is one theorist that describes
behavioral change as a balance of forces working in opposite directions. Driving forces push
people towards change, while restraining forces hinder it (Lewin, 1947). The first step in
Lewin’s change theory is the unfreezing stage. During this stage driving forces are encouraged to
move people away from the status quo and restraining forces are discouraged. This can be
accomplished by educating people about the importance of change, helping people to recognize
14
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the need for change, and working with people for ideas for change (Lewin, 1947). During the
unfreezing stage, the team spoke with clinicians in the clinic about the current process and the
ways in which change could be implemented.
The second step in Lewin’s change theory is the movement phase. This means movement
towards a new equilibrium. This can be accomplished by helping people accept that the old way
was not beneficial, and change is needed. Encouraging people to see the situation from a fresh
perspective helps with this. Including people in the process can also help facilitate change.
Listening to ideas, providing rationale using research, and gaining support from respected
members of management provides the best scenario for Lewin’s second step (Lewin, 1947). The
team utilized the movement stage by implementing PDSA cycles for change and using the results
of each previous cycle to guide changes to the following cycle.
The final step in Lewin’s change theory is the refreezing stage. This occurs after the
change is implemented to maintain the process. Without refreezing, people will likely return to
the previous status quo and change will not be sustained. Placing value in the change and making
sure the leader continues to encourage it is important to make the change stick. Another way of
doing this is to make the change formal and part of a written policy (Lewin, 1947). The most
important thing to remember is that the driving forces must be stronger than the restraining
forces. Otherwise change will not occur (Lewin, 1947). Providers must change their behavior to
discuss, screen, and educate about lung cancer. Once a process is established, the team could use
the refreezing stage to maintain the course.
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Sample
For each PDSA cycle, a convenience sample of patients seen on the dates of the cycles
were used, and a convenience sample of providers present on the dates of the cycles participated.
The same patients were used for pre- and post- cycle measures. Inclusion criteria for the patients
were patients aged 55 to 80 years old who were current or former cigarette smokers. Inclusion
criteria for the providers were providers present on a specific family-medicine team within the
clinic.
Measures
Pre and post measures included demographic variables, smoking history documentation,
and LDCT orders. Data collection was completed using a chart audit. Qualitative data were
collected using a provider and CST survey about the interventions. Results were stored in a
secure, password protected, SharePoint site that only the quality improvement team had access
to.
Analysis
Descriptive statistics were used to summarize the results. Fisher’s exact test for statistical
significance was used to compare each PDSA intervention cycle due to the small sample size and
small number of variables. The cycles were compared for statistically significant results to
describe the effectiveness of one intervention versus another. The number of patients with
documented smoking histories, including pack-years, was compared with each PDSA cycle. The
number of LDCT scan orders for lung cancer screening were also compared with each PDSA
intervention cycle. Also, the number of orders for lung cancer screening orders and smoking
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history documentation with pack-years was compared pre- and post-intervention. All statistical
analysis was completed using SPSS 22 (IBM Corp., 2013).
Ethical Considerations
Patients identifying data was de-identified during data collection in accordance with the
Health Insurance Portability and Accountability Act (HIPAA). This quality improvement project
did not pose any physical or psychological harm to patients or staff involved.
Results
PDSA Cycle One
The first PDSA cycle included two physicians and took between two and five days. A
representative from the quality improvement team stapled educational flyers about lung cancer
screening, by the Kentucky LEADS Collaborative, to every rooming card for every patient seen
by the two participating physicians during the cycle. The rooming cards were already in use by
the clinic and included the patient’s current vital signs and important follow-up information. The
team chose the flyer because it provides information about how to calculate pack-years, who
qualifies for screening, why screening is important, and pros and cons of screening in
understandable language. The patients took the rooming cards home with the flyer after the
appointment. The investigator was not present for this cycle; therefore, every patient seen by the
providers during the cycle was given the flyers. This way, no one who might qualify for
screening would be missed. The only information given to the providers was that the flyers
would be attached to the rooming cards. One physician was only in clinic for two days, and the
other physician was in clinic for five days.
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Results of Cycle One are shown in Figure 1. For the first cycle, smoking history
documentation increased from 0% to 26.7% (p=0.10). The LDCT scan orders increased from 7%
to 14.3% (p=0.99). One of the patients seen had a life-limiting illness that disqualified the patient
from lung cancer screening. This patient was excluded in the LDCT scan results (n=14) but
included in the smoking history results (n=15).
Table 1.
PDSA Cycle One Results

Smoking History
Documentation

LDCT Ordered

Pre

Post

p

n=14

n=15

0.10

0 (0%)

4 (26.7%)

n=14

n=14

1 (7%)

2 (14.3%)

0.99

PDSA Cycle Two
For Cycle Two, the team wanted to educate the providers and CSTs involved about the
study and flyer, hoping this would increase compliance with the cycle. The second PDSA
included three physicians, one nurse practitioner and four CSTs from a different team than cycle
one because the providers from cycle one were not available that day. This cycle lasted for one
day and the primary investigator was present the entire day to answer questions. The same lung
cancer screening flyer from cycle one was stapled to rooming cards for only patients aged 55 to
80 years old. The investigator educated the providers about the purpose of the study, the flyers
themselves, the importance of documenting pack-years, and ordering a LDCT for lung cancer
18
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screening when necessary. Results of cycle two are shown in Table 2. During PDSA Cycle Two,
smoking history documentation increased from 0% to 25% (p=0.47) and LDCT scan orders
increased from 16.7% to 37.5% (p=0.58).
Table 2.
PDSA Cycle Two Results

Smoking History
Documentation

LDCT Ordered

Pre

Post

p

n=6

n=8

0.47

0 (0%)

2 (25%)

n=6

n=8

1 (16.7%)

3 (37.5%)

0.58

PDSA Cycle Three
In PDSA Cycle Three the team wanted to make collecting a complete smoking history
easier. The same lung cancer screening flyer from cycles one and two was stapled to rooming
cards for patients aged 55 to 80 years old. For this cycle, the quality improvement team created a
sticker that asked specific smoking history questions. This sticker was placed on the rooming
cards along with the flyers. The CSTs were educated about completing the questions on the
sticker during the rooming process. The providers were given the same education as cycle two
and were also shown the sticker and where to chart a complete smoking history within the
electronic health record. The third PDSA cycle included three physicians, one nurse practitioner
and four CSTs. The cycle lasted one day, and the investigator was present the entire day to
answer questions. See Table 3 for the results of Cycle Three. There was no increase in smoking
19
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history documentation or LDCT orders with this cycle. Because of these results, the team wanted
to survey the providers and CSTs about the processes used this far.
Table 3.
PDSA Cycle Three Results

Smoking History
Documentation

LDCT Ordered

Pre

Post

p

n=6

n=5

0.99

0 (0%)

0 (0%)

n=6

n=5

0 (0%)

0 (0%)

0.99

PDSA Cycle Four
After the results from Cycle Three, the team decided to survey providers and CSTs about
the process used in the previous three cycles. The survey was developed by the team and
consisted of questions about the importance of lung cancer screening and the process chosen to
increase screening so far (See Figure 6). Three out of eight surveys were returned. One provider
and one CST agreed that lung cancer screening is very important, and they would like to
continue the process chosen to increase screening. The remaining provider believed screening is
very important but did not like the physical flyers on the rooming cards because they added more
materials to the exam room. Considering most of the results favored the process being used, the
team decided to complete Cycle Four using the flyers and smoking history stickers, hoping for a
larger sample size.
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The same interventions as Cycle Three were used in Cycle Four, with one addition. The
CSTs showed the investigator the completed smoking history sticker after each appointment with
a patient between the ages of 55 and 80 years. The fourth PDSA included two physicians and one
nurse practitioner. The cycle lasted for one day and the investigator was present for the entire
day to answer questions. Three patients seen did not qualify for an LDCT because of a lifelimiting illness or a previous LDCT within the past year. These three patients were not included
in the results for LDCT orders. The results of cycle four can be seen in Table 4. Smoking history
documentation increased from 22% to 33.3% (p=0.99) and LDCT order increased from 22% to
28.6% (p=0.99).
Table 4
PDSA Cycle Four Results

Smoking History
Documentation

LDCT Ordered

Pre

Post

p

n=9

n=9

0.99

2 (22%)

3 (33.3%)

n=9

n=7

2 (22%)

2 (28.6%)

0.99

Summary of Results
Tables 5 and 6 show a summary of results from all four PDSA cycles. There was no
statistically significant difference between each PDSA cycle intervention on smoking history
documentation (p=0.64) or LDCT orders (p=0.44). However, while there was no difference
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between PDSA cycle interventions, smoking history documentation and LDCT orders increased
for every PDSA cycle except cycle three.

Table 5
Smoking history documentation including pack-years for current and former smokers by
intervention
n
PDSA Cycle 1
PDSA Cycle 2
PDSA Cycle 3
PDSA Cycle 4

15
8
5
9

Pack-Years
documented
4 (26.7%)
2 (25%)
0 (0%)
3 (33.3%)

No pack years
documented
11 (73.3%)
6 (75%)
5 (100%)
6 (66.7%)

p
0.64

Table 6.
LDCT orders among current and former smokers by intervention
n
PDSA Cycle 1
PDSA Cycle 2
PDSA Cycle 3
PDSA Cycle 4

14
8
5
7

Pack-Years
documented
2 (14.3%)
3 (37.5%)
0 (0%)
2 (28.6%)

No pack years
documented
12 (85.7%)
5 (62.5%)
5 (100%)
5 (71.4%)

p
0.44

Figures 1 and 2 show the different processes providers chose for current and former
smokers in all PDSA cycles combined. For current smokers, if the provider documented a
smoking history, 100% of those patients received lung cancer screening orders. The results
varied for former smokers. Four former smokers did not get LDCT orders even though their
smoking histories were documented. Table 7 shows the difference in LDCT orders between
current and former smoker results by each PDSA cycle. Cycle four showed a statistically
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significant difference between former and current smokers and LDCT orders. Current smokers
were more likely to receive LDCT orders than former smokers.
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Figure 1.
All PDSA Cycle Results for Current Smokers
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n=3

n=3
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Smoking History
Discussion Documented
(no pack-years)

n=12

n=4

n=2
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n=2

Up-to-Date with
Screening
n=2

n=3
No Smoking Hx
discussion nor Pack-Years
Documented
n=5

Does Not Qualify
n=1

CT Not Ordered
n=2
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Figure 2.
All PDSA Cycle Results for Former Smokers
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Table 7.
LDCT Orders Between Current and Former Smokers by each PDSA Cycle
n
PDSA
Cycle 1
PDSA
Cycle 2
PDSA
Cycle 3
PDSA
Cycle 4

14

Former
smokers
10

Received
CT orders
1 (10%)

Current
smokers
4

Received
CT orders
1 (25%)

p
0.51

8

5

1 (20%)

3

2 (66.7%)

0.46

5

5

0 (0%)

0

0

--

7

5

0 (0%)

2

2 (100%)

0.05

Discussion
Summary
PDSA cycles one, two, and four showed a nonsignificant increase in smoking history
documentation and LDCT scan orders. The third PDSA cycle yielded zero documentation or
LDCT orders before and after the intervention. Provider feedback indicated strong agreement
with the importance of lung cancer screening and satisfaction with the new process being trialed.
The fourth PDSA cycle’s intervention was the same as Cycle Three, except that the CSTs were
held accountable for filling out the smoking history sticker. This suggests that accountability
might contribute to better results. Interestingly, this study revealed a significant difference in
LDCT orders between current and former smokers, with more LDCT orders for current than
former smokers. Because there were no significant differences between PDSA cycles, the team
cannot recommend a specific intervention; however, after reminders for lung cancer screening
were implemented smoking history documentation and LDCT scan orders increased. More
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PDSA cycles should be completed to identify the best version of the reminder and then to trial it
on a larger scale.
Interpretation
Documentation of a complete smoking history is a challenge both nationally and locally.
It is difficult to calculate accurate lung cancer screening rates without accurate documentation of
a smoking history. Research suggests that physical or electronic reminders will not only increase
documentation, but also increase LDCT scan orders for lung cancer screening
(Polubriaginof, Salmasian, Albert, & Vawdrey, 2018; Modin et al., 2016). The goal of this study
was to create a process for documenting adequate smoking histories for patients who qualify for
lung cancer screening. Overall, documentation increased with each intervention, except PDSA
cycle three. Most of the providers and CSTs surveyed were satisfied with the lung cancer
screening flyers and smoking history stickers trialed. This suggests that expanding this trial for a
larger sample size could yield positive results.
This study found that current smokers were more likely to receive LDCT scan orders than
former smokers. These results were significant for PDSA Cycle Four. There is very little
research comparing the two groups for lung cancer screening, so more research is needed to
determine whether this is a true disparity, and if so, the reasons behind it so they can be
addressed. The chance of dying from lung cancer is cut in half when a person quits smoking for
ten years (CDC, 2019). Potentially, providers are more aware of the risks of lung cancer with
current smokers, and therefore are more likely to order lung cancer screening for current
smokers. It is possible that a large number of people who qualify for screening are not being
screened and will suffer from potentially avoidable morbidity and/or mortality.
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The third PDSA cycle showed no documentation or LDCT orders either before or after
the intervention. The exact same intervention was used for PDSA cycle four and showed positive
results. The only difference was that the CSTs were held accountable by showing the
investigator the completed smoking history sticker. Many hand hygiene studies have suggested
that compliance increases with accountability (Cantrell, 2018). When a person is required to
show proof or knows that someone is watching, that person is more likely to complete necessary
tasks such as hand hygiene (Johnson et al., 2014). Similar conclusions could be inferred about
smoking history documentation based on the results of this study.
Recommendations
The process used to increase documentation in this study did increase smoking history
documentation rates. The clinic should complete more PDSA cycles and separate the
interventions to explore any differences between the flyers and smoking history stickers.
Subsequent cycles should start with just the flyer, then just the sticker, and compare results.
Although the sample size in this study was small, it suggests that the process for increasing
documentation could work with a larger sample size. The next PDSA cycles should continue
until a large enough sample size is reached to yield significant results. The clinic would also
benefit from educating staff about a specific location for smoking history documentation. Part of
the intervention included showing providers where to document within the electronic health
record, but almost none of the providers utilized that location, making data collection and
interpretation very difficult. Once documentation compliance is steadily increasing, another
quality improvement initiative could focus on educating providers about documenting in one
location. This would also make calculating screening rates within the clinic easier. Another
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recommendation for the clinic would be to add the specific smoking history questions to the
annual review so that it could be completed yearly on every patient by the CST.
Nationally and locally, there needs to be more research comparing the rates of lung
cancer screenings for current and former smokers. The results of this study suggest that current
smokers are more likely to receive lung cancer screening orders than former smokers. There is
not much research comparing the two groups for lung cancer screening. The relative risk for lung
cancer mortality decreases the earlier in life a person quits smoking tobacco. The relative risk for
a person quitting smoking at age 60 is 45%, and 20% for age 50 (Halpern, Gillespie, & Warner,
1993). Former smokers do have less risk for dying from lung cancer when they have been
tobacco free for ten years, but their risk is still higher than people who have never smoked
tobacco (CDC, 2018). For this reason, former smokers aged 55 to 80 years who have a 30-packyear history and have quit smoking within 15 years are recommended to receive lung cancer
screening with LDCT (Humphrey et al., 2013).
Cycle Four yielded better results than Cycle Three possibly due to holding the CSTs
accountable. The clinic could incorporate accountability with documentation and screening
orders by auditing charts for completed smoking histories within the annual review or in the
provider’s notes. Electronically auditing employee charting, and emailing employees with
decreased compliance, could hold clinic employees accountable, making smoking history
documentation and LDCT orders more likely to be completed.
Limitations
The sample size for each PDSA cycle was small, thus the power to detect a statistically
significant difference was weak. A larger sample size might yield more robust findings.

29

INCREASING LUNG CANCER SCREENING RATES
However, PDSA cycles are meant to be small cycles of change in order to recommend
interventions on a lager scale. Another limitation was the short time frame the in which PDSA
cycles were implemented. PDSA cycles are typically completed in small time-frames initially,
but the one day duration of the intervention led to a small sample size. The next study in this
clinic should take place over a longer period such as a week or two to hopefully yield a larger
sample size, and thus more data for analysis. The final limitation was individual provider
behavior. Providers documented differently and in different locations within the electronic health
record. This made data collection difficult. Some providers did not document anything but did
order lung cancer screening. While it can be assumed that a lung cancer screening discussion
took place, there was no documentation of it. One possible reason for this is because it is more
time consuming to chart a complete smoking history in the designated area of the electronic
health record. Another reason is that providers might believe that it is tedious to chart in a
specific area, if they have already charted in another section of the note. This study partially
focused on increasing documentation, but more studies are needed to increase compliance with
documentation.
Conclusion
Kentucky leads the nation in new lung cancer cases each year (U.S. Cancer Statistics
Working Group, 2018). It is difficult to obtain accurate lung cancer screening rates both
nationally, and locally because of lack of accurate documentation. This study focused on
increasing smoking history documentation and increasing lung cancer screening orders. The
results suggest that reminders, such as educational lung cancer screening flyers and smoking
history stickers, could increase documentation and LDCT scan orders.
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The clinic should continue PDSA cycles by separating the flyer intervention and smoking
history sticker intervention to determine if there is a significant difference between each. Once a
process is established, the chosen prompting intervention should be implemented clinic wide.
There should be more research about the disparity identified between former and current
smokers with lung cancer screening orders. This study showed a significant difference between
current and former smokers in that current smokers are more likely to receive lung cancer
screening orders. This warrants further investigation as to why current smokers are more likely
to receive orders, because it is possible healthcare providers are not screening a large group of
people who qualify. While current smokers are more likely to be diagnosed with and die from
lung cancer, former smokers also have an increased risk of developing and dying from lung
cancer (CDC, 2018). Future studies should further investigate this disparity between screening
rates for smokers and non-smokers and seek to identify the most effective reminders to facilitate
adequate smoking history documentation and LDCT scan orders.
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Figure 3. Flowchart for Patient Appointments
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Figure 4. Fishbone Diagram
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Figure 5. Five Why’s Chart
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Figure 6. Survey After Third PDSA Cycle
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